Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178243 · ClinicalTrials.gov registry record · Phase 1
Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation
A Phase 1 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00178243 is a Phase 1 study that has completed, run by University of Rochester.
The verdict
NCT00178243, a Phase 1 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
A study is being conducted by the University of Rochester Cancer Center (URCC) in which patients with liver cancer will be treated with high dose conformal radiation therapy. This type of radiation uses new techniques which aim the radiation to the sites of disease allowing the tumor to receive a high dose and the surrounding normal liver tissue to receive a low enough dose that the normal tissue should remain free from injury. The purpose of the study is to determine if the conformal radiation therapy is safe, tolerable and effective in treating liver cancer and to determine the side effects caused by this treatment. A second objective is to determine if the levels of a special type of protein (called cytokines) found in the blood are related to this treatment.
Interventions
- PROCEDURE 3D Conformal Radiation Therapy and Radiosurgery
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178243
The ClinicalTrials.gov registry entry for NCT00178243 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 3D Conformal Radiation Therapy and Radiosurgery is the first listed.
NCT00178243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00178243 about?
NCT00178243 is a clinical study titled "Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation". A study is being conducted by the University of Rochester Cancer Center (URCC) in which patients with liver cancer will be treated with high dose conformal radiation therapy. This type of radiation uses new techniques which aim the radiation to the sites of disease allowing the tumor to receive a hi...
What is the current status of trial NCT00178243?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00178243?
The interventions under investigation include: 3D Conformal Radiation Therapy and Radiosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT00178243?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.